share_log

CG Oncology | 4: Statement of changes in beneficial ownership of securities-10% Owner Decheng Capital Global Life Sciences Fund IV, L.P.

SEC announcement ·  Jan 31 16:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more